<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528189</url>
  </required_header>
  <id_info>
    <org_study_id>2012-01</org_study_id>
    <nct_id>NCT01528189</nct_id>
  </id_info>
  <brief_title>Effect of High Dose Insulin on Infectious Complications Following Major Surgery</brief_title>
  <official_title>Effect of Hyperinsulinemic Normoglycemic Clamp (HINC) on Infectious Complications Following Major Abdominal Surgery. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Centre/Research Institute of the McGill University Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Centre/Research Institute of the McGill University Health Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite improvements in surgical techniques and perioperative care, the high incidence of
      postoperative surgical site infections remains a major problem in patients undergoing major
      abdominal surgery (liver, pancreatic and colorectal surgery).

      Using the hyperinsulinemic-normoglycemic clamp technique, i.e. continuous infusion of insulin
      combined with dextrose titrated to &quot;clamp&quot; blood glucose between 4 and 6 mmol/L, we
      successfully established and preserved normoglycemia during the perioperative period. Our
      objective of this study is to determine if the maintenance of perioperative normoglycemia by
      a hyperinsulinemic normoglycemic clamp reduces the rates of incisional and space/ surgical
      site infections following abdominal surgery (liver, pancreatic and colorectal surgery).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>for 30 days after surgery</time_frame>
    <description>Surgical site infections will be defined according to the CDC's NNIS system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical morbidity</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Surgical morbidity in the 30 days following the operation will be assessed as per Clavien score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Surgical Site Infection After Major Surgery</condition>
  <arm_group>
    <arm_group_label>Standard glucose management</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperinsulinemic normoglycemic clamp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyperinsulinemic normoglycemic clamp</intervention_name>
    <description>Patients will receive an IV infusion of 2 mU/kg/min (0.12 U/kg/hour) starting in the operating room. Dextrose 20% will be titrated to maintain blood glucose between 4 and 6 mmol/l. At the end of surgery, the insulin infusion will be stopped and the dextrose infusion weaned off in the postanesthesia care unit.</description>
    <arm_group_label>Hyperinsulinemic normoglycemic clamp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard glucose management</intervention_name>
    <description>Blood glucose levels will be treated by a standard insulin sliding scale.</description>
    <arm_group_label>Standard glucose management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years old

          -  elective liver, pancreatic or colorectal surgery

          -  ability to give informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralph Lattermann, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesia, McGill University Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ralph Lattermann, MD PhD</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>37023</phone_ext>
    <email>ralph.lattermann@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Schricker, MD PhD</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>36057</phone_ext>
    <email>thomas.schricker@mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Victoria Hospital, McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralph Lattermann, MD PhD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>35802</phone_ext>
      <email>ralph.lattermann@muhc.mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Schricker, MD PhD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>36057</phone_ext>
      <email>thomas.schricker@mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Ralph Lattermann, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Schricker, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Carvalho, MD MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Metrakos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Linda Wykes, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mazen Hassanain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ralph Lattermann, MD PhD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>37023</phone_ext>
      <email>ralph.lattermann@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Schricker, MD PhD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>36057</phone_ext>
      <email>thomas.schricker@mcgill.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Roupen Hatzakorzian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Metrakos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prosanto Chaudhury, MD MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Frenette, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universidad de Chile</name>
      <address>
        <city>Independencia</city>
        <state>Santiago</state>
        <zip>8380456</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniela B Advis, M.D.</last_name>
      <phone>+5629788211</phone>
      <email>dbravoadvis@uchile.cl</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Chile</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>February 3, 2012</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <last_update_submitted>November 19, 2018</last_update_submitted>
  <last_update_submitted_qc>November 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</investigator_affiliation>
    <investigator_full_name>Ralph Lattermann</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>Insulin, surgery, infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

